Surgery – Controlled release therapeutic device or system – Implanted dynamic device or system
Reexamination Certificate
2005-11-29
2005-11-29
Kennedy, Sharon (Department: 3762)
Surgery
Controlled release therapeutic device or system
Implanted dynamic device or system
C128S898000
Reexamination Certificate
active
06969383
ABSTRACT:
A method for treating severe tinnitus is disclosed. The method of the present invention comprises implanting a catheter into a patient and administering a drug formulation or fluid comprising a therapeutic agent intrathecally into the patient's cerebrospinal fluid.
REFERENCES:
patent: 4445500 (1984-05-01), Osterholm
patent: 5496369 (1996-03-01), Howard, III
patent: 5676655 (1997-10-01), Howard, III et al.
patent: 5711316 (1998-01-01), Elsberry et al.
patent: 5713847 (1998-02-01), Howard, III et al.
patent: 5863941 (1999-01-01), Liedtke
patent: 6265379 (2001-07-01), Donovan
patent: 6309410 (2001-10-01), Kuzma et al.
patent: 6358926 (2002-03-01), Donovan
patent: 6656172 (2003-12-01), Hildebrand
patent: 2002/0156512 (2002-10-01), Borkan
Kaneko, Megumi et al., Intrathecally Administered Gabapentin Inhibits Formalin-Evoked Nociception and the Expression of Fos-Like Immunoreactivity in the Spinal Cord of the Rat, J. Pharmacol Exp Ther, vol. 292, Issue 2, 743-751, Feb. 2000.
Menkes, D B, et al.; “Sodium Valproate for Tinnitus”; Journal of Neurology Neurosurgery & Psychiarty, XX, XX, vol. 65, No. 5, (Nov. 1998) p. 803.
Simpson, J J, et al.; “A Review of Evidence in Support of a Role for 5-HT in the Perception of Tinnitus”; Hearing Research 2000 Netherlands, vol. 145, No. 1-2, 2000, pp. 1-7.
Uno, I. et al.; “A Rare Complication of Stellate Ganglion Block a Case Report”; Practica Otologica Kyoto; vol. 77, No. 12, 1984, pp. 2515-2519.
Gentili, Marc E.; “Epidural Fibrin Glue Injection Stops Postdural Puncture Headache in Patient With Long-Term Intrathecal Catheterization.”; Regional Anesthesia and Pain Medicine, United States 2003; Jan.-Feb., vol. 28, No. 1; (Jan. 2003), p. 70.
Coffey, R J, et al.; “Abrupt Intrathecal Baciofen Withdrawal: Management of Potentially Life-Threatening Sequelae”; Neuromodulation 2001 United States, vol. 4, No. 4, 2001, pp. 142-146.
Lewis, J.E., S.D.G. Stephens, et al, “Tinnitus and suicide.” Jul. 7, 1993, pp. 50-54, vol. 19, Clin Ototaryngol.
McFadden, D., Tinnitus: Facts, Theories, and Treatments, 1982, pp. 1-9, National Academy Press, Washington D.C.
Sataloff, J., R.T. Sataloff, et al., “Tinnitus and vertigo in healthy senior citizens without a history of noise exposure.” Mar. 1987, pp. 87-89, vol. 2, Thieme Medical Publishers, Inc., New York, NY.
Axelsson, A. and A. Ringdahl, “Tinnitus-a study of its prevalence and characteristics.”, 1989, pp. 53-56, vol. 23, British Journal of Audiology.
Coles, R. R. A., Thompson, et al., “Intra-tympanic injections in the treatment of tinnitus.”, 1992, pp. 240-242, vol. 17, Clin Otolaryngol.
Dobie, R.A., “A review of randomized clinical trials in tinnitus.”, The Laryngoscope, Aug. 1999, pp. 1202-1211, Lippincott Williams & Wilkins, Inc., Philadelphia.
Lockwood, A.H., R.J. Salvi, et al, “The functional neuroanatomy of tinnitus: Evidence for limbic system links and neural plasticity.”, Jan., 1998, Neurology, pp. 114-120, vol. 50, American Academy of Neurology.
Moller, A.R., “Symptoms and signs caused by neural plasticity.” Neurological Research, Sep., 2001, pp. 565-572, vol. 23, Forefront Publishing Group.
Den Hartigh, J., C. G. J. M. Hilders, et al., “Tinnitus suppression by Intravanous lidocaine in relation to its plasma concentration.” Clinical Pharmacology & Therapeutics, Oct. 1993, pp. 415-420, vol. 54 No. 4, Mosby-Year Book, Inc.
Ochi, K. and J.J. Eggermont, “Effects of salicylate on neural activity in cat primary auditory cortex.” Hearing Research, 1996, pp. 63-76, vol. 95, Elsevier Science B.V.
Caspary, D.M., J. C.Milbrandt, et al., “Central Auditory Aging: GABA Changes in the Inferior Colliculus.”Experimental Gerontology, 1995, pp. 349-360, vol. 30 Nos. 3/4, Elsevier Science Ltd. , USA.
McGeer, E. G. and P. L. McGeer, “Age Changes in the Human for Some Enzymes Associated with Metabolism of the Catecholamines, GABA and Acetycholine.” Neurobiology of Aging, 1975, pp. 287-305, Plenum Press, New York.
Raza, A., J. C. Milbrandt, et al., “Age-Related Changes in Brainstem Auditory Neurotransmitters: Measures of GABA and Acetylcholine Function.” Hearing Research, 1994, pp. 221-230, vol. 77, Elsevier Science B. V.
Araki, T., H. Kato, et al., “Selective changes of neurotransmitter receptors in middle-aged gerbil brain.” Neurochem. Int., 1993, pp. 541-548, vol. 23 No. 6, Pergamon Press Ltd.
Mildbrandt, J. C., R. L. Albin, et al., “Age-Related Decrease in GABAaReceptor Binding in the Fischer 344 Rat Inferior Colliculus.” Neurobiology of Aging, 1994, pp. 699-703, vol. 15 No. 6, Elsevier Science Ltd., USA.
Moller, A. R., M. B. Moller, et al., “Some Forms of Tinnitus May Involve the Extralemniscal Auditory Pathway.” Laryngoscope, Oct 1992, pp. 1165-1171.
Szczrpaniak, W. S. and A. R. Moller, “Effects of L-Baclofen and D-Bachlofen on the Auditory System: A Study of Click-Evoked Potentials From the Inferior Colliculus in the Rat.” Ann Otol Rhinol Laryngol, 1995, pp. 399-404.
Szczrpaniak, W. S. and A. R. Moller, “Effects of (-) baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis.” Hearing Research, 1996, pp. 46-53, Elsevier Science B.V.
Lees, A. J., C. R. Clarke et al., “Hallucinations After Withdrawal of Baclofen.” The Lancet, Apr. 16, 1977.
Zapp, J. J., “Gabapentin for the treatment of tinnitus: A case report.” ENT-Ear, Nose & Throat Journal, Feb. 2001, pp. 114-116.
Kuzniecky, R. S. Ho, et al., “Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults.” Neurology, Feb. 2002, pp. 368-372, AAN Enterprises, Inc.
Petroff, O. A., F. Hyder, et al., “Effects of Gabapentin on Brain GABA, Homocamosine, and Pyrrolidinone in Epilepsy Patients.” Epilepsia, 2000, pp. 675-680, Lippincott Williams & Wilkins, Inc., Baltimore.
Westerberg, B. D., J. B. Roberson, et al., “A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus.” The American Journal of Otology, 1996, pp. 896-903, The American Journal of Otology, Inc.
Coffey, R. J., D. Cahill, et al., “Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.” J Neurosurg, Feb. 1993, pp. 226-232, vol. 78.
Meythaler, J. M., S. Guin-Renfroe, et al., “Continuously Infused Intrathecal Baclofen for Spastic/Dystonic Hempiplegia.” American Journal of Physical Medicine & Rehabilitation, 1999, pp. 155-161, No. 9, Lippincott Williams & Wilkins, Inc.
Penn, R. D., S. M. Savoy, et al., “Intrathecal Baclofen for Severe Spinal Spasticity.” New England Journal of Medicine, Jun. 8, 1989, pp. 1571-1521, vol. 320.
Knutsson, E., U. Lindblom, et al., “Plasma and Cerebrospinal Fluid Levels of Baclofen (Lioresal®) at Optimal Therapeutic Responses in Spastic Paresis.” Journal of the neurological Sciences, 1974, pp. 473-484, vol. 23, Elsevier Scientific Publishing Company, Netherlands.
Kroin, J. S., “Intrathecal Drug Administration.” Clin. Pharmacokinet. 1992, pp. 319-326, vol. 22 (5), Adis International Limited.
Kroin, J. S. and R.D. Penn, “Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen”, 1991, pp. 67-77, Parthenon Publishing.
Muller, H., J. Zierski, et al. “Pharmacokinetics of Intrathecal Baclofen.” 1998, pp. 223-226, Springer-Verlag.
MilBrandt, JC, et al., “GAD levels and muscimol binding in rat inferior colliculus following acoustic trauma.” Hearing Research, 2000, pp. 251-260, vol. 147 (1-2), Elsevier Science B.V.
Caspary, D.M., T.M. Holder, et al., “Age-Related Changes in GABAAReceptor Subunit Composition and Fun
Banner & Witcoff , Ltd.
Kennedy Sharon
Medtronic Inc.
LandOfFree
Method for treating severe tinnitus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating severe tinnitus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating severe tinnitus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3454612